BME · BlackRock Health Sciences Trust · Fund Holdings

$44.22 +0.16 (+0.36%) At close · Sep 11

Market Cap

$577.06M

12.92M

Portfolio holdings reported by registered funds to the SEC on Form N-PORT — the individual securities a fund owns. Only mutual funds, ETFs and closed-end funds file N-PORT, so operating companies show no data.

BlackRock Health Sciences Trust

Reported 2026-06-30

Net Assets

$571,466,391

Total Assets

$573,632,228

Holdings

156

Filed

2026-08-25

Holding	CUSIP	Balance	Units	Value	% Net Assets	Category	Country
Eli Lilly & Co	532457108	59,379	NS	$71,220,954	12.46%	EC	US
Johnson & Johnson	478160104	175,604	NS	$44,598,148	7.80%	EC	US
UnitedHealth Group Inc	91324P102	84,166	NS	$34,981,915	6.12%	EC	US
Merck & Co Inc	58933Y105	232,628	NS	$29,892,698	5.23%	EC	US
AbbVie Inc	00287Y109	115,083	NS	$28,959,486	5.07%	EC	US
Gilead Sciences Inc	375558103	166,662	NS	$21,056,077	3.68%	EC	US
Amgen Inc	031162100	53,219	NS	$19,271,664	3.37%	EC	US
BlackRock Liquidity Funds	09248U718	19,047,042	NS	$19,047,042	3.33%	STIV	US
Thermo Fisher Scientific Inc	883556102	33,830	NS	$16,961,009	2.97%	EC	US
Vertex Pharmaceuticals Inc	92532F100	31,983	NS	$15,886,916	2.78%	EC	US
Edwards Lifesciences Corp	28176E108	149,905	NS	$13,560,406	2.37%	EC	US
Danaher Corp	235851102	57,611	NS	$10,973,743	1.92%	EC	US
Abbott Laboratories	002824100	119,561	NS	$10,848,965	1.90%	EC	US
Elevance Health Inc	036752103	27,515	NS	$10,640,876	1.86%	EC	US
Pfizer Inc	717081103	354,263	NS	$8,530,653	1.49%	EC	US
Argenx SE	04016X101	8,058	NS	$7,475,971	1.31%	EC	NL
Boston Scientific Corp	101137107	173,789	NS	$7,417,315	1.30%	EC	US
Biogen Inc	09062X103	31,869	NS	$6,885,616	1.20%	EC	US
Teva Pharmaceutical Industries Ltd	881624209	195,347	NS	$6,618,356	1.16%	EC	IL
Intuitive Surgical Inc	46120E602	16,457	NS	$6,544,620	1.15%	EC	US
Stryker Corp	863667101	19,938	NS	$6,277,280	1.10%	EC	US
Revolution Medicines Inc	76155X100	32,101	NS	$6,011,875	1.05%	EC	US
Moderna Inc	60770K107	81,325	NS	$5,695,190	1.00%	EC	US
Waters Corp	941848103	15,073	NS	$5,652,978	0.99%	EC	US
Cytokinetics Inc	23282W605	59,440	NS	$5,063,694	0.89%	EC	US
Regeneron Pharmaceuticals Inc	75886F107	7,712	NS	$4,808,740	0.84%	EC	US
Bristol-Myers Squibb Co	110122108	81,467	NS	$4,694,129	0.82%	EC	US
CVS Health Corp	126650100	41,701	NS	$4,313,968	0.75%	EC	US
Humana Inc	444859102	10,819	NS	$4,297,523	0.75%	EC	US
AstraZeneca PLC	000000000	22,678	NS	$4,234,078	0.74%	EC	GB
Cogent Biosciences Inc	19240Q201	103,620	NS	$4,010,094	0.70%	EC	US
HCA Healthcare Inc	40412C101	10,127	NS	$3,948,416	0.69%	EC	US
Incyte Corp	45337C102	34,568	NS	$3,918,628	0.69%	EC	US
Dexcom Inc	252131107	57,910	NS	$3,900,239	0.68%	EC	US
Galderma Group AG	000000000	16,599	NS	$3,775,400	0.66%	EC	CH
Penumbra Inc	70975L107	11,606	NS	$3,664,595	0.64%	EC	US
Protagonist Therapeutics Inc	74366E102	29,705	NS	$3,641,239	0.64%	EC	US
Nuvalent Inc	670703107	28,618	NS	$3,534,323	0.62%	EC	US
Novartis AG	66987V109	21,810	NS	$3,418,063	0.60%	EC	CH
Insmed Inc	457669307	30,918	NS	$3,296,477	0.58%	EC	US
Agilent Technologies Inc	00846U101	23,884	NS	$3,172,512	0.56%	EC	US
Apogee Therapeutics Inc	03770N101	23,470	NS	$3,115,173	0.55%	EC	US
IDEXX Laboratories Inc	45168D104	5,896	NS	$3,103,890	0.54%	EC	US
Rhythm Pharmaceuticals Inc	76243J105	27,009	NS	$2,998,809	0.52%	EC	US
United Therapeutics Corp	91307C102	4,903	NS	$2,656,592	0.46%	EC	US
Illumina Inc	452327109	14,875	NS	$2,615,471	0.46%	EC	US
Alnylam Pharmaceuticals Inc	02043Q107	8,378	NS	$2,522,029	0.44%	EC	US
IQVIA Holdings Inc	46266C105	12,502	NS	$2,415,636	0.42%	EC	US
Oruka Therapeutics Inc	687604108	23,783	NS	$2,263,428	0.40%	EC	US
Bruker Corp	116794108	36,061	NS	$2,170,151	0.38%	EC	US

Showing 1–50 of 156 holdings

Key facts CIK 1314966 CUSIP 09250W107 13F (30d) 12 filings 12 filers Visit website Investor relations